IVAN ROSAS to Vascular Endothelial Growth Factor Receptor-3
This is a "connection" page, showing publications IVAN ROSAS has written about Vascular Endothelial Growth Factor Receptor-3.
Connection Strength
0.291
-
Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis. Chest. 2018 11; 154(5):1070-1082.
Score: 0.160
-
Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection. J Clin Invest. 2015 Nov 02; 125(11):4255-68.
Score: 0.131